Pretraživanje
Prikaz rezultata 1-8 od 8
Macrophage migration inhibitory factor as potential therapeutic target for prevention and treatment of autoimmune diabetogenesis. Lessons from animal models
(International Journal of Molecular Medicine, 2009)
MIF antagonists are anti-diabetogenic.
(Abstracts of Papers of the American Chemical Society, 2004)
Prevention of experimental autoimmune diabetes with complete Freund's adjuvant in mice - role of nitric oxide
(Inflammation Research, 2005)
Antidiabetogenic effect of mycophenolate mofetil is associated with down-regulation of adhesive interactions and autoreactive cell activation
(Immunology of Diabetes: Autoimmune Mechanisms and the Prevention and Cure of Type 1 Diabetes, 2002)